Clinical Trial: An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807969) titled 'An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)' on Sept. 03.

Brief Summary: The primary purpose of the study is to assess the long term safety of intravitreal (IVT) injections of vonaprument.

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Geographic Atrophy

Intervention: DRUG: Vonaprument

Form: solution for injection; Route of Administration: IVT injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Annexon, Inc.

Published by HT Digital Content Services with permission from Healt...